Critically Ill: Clinical Trials

2 trials for Critically Ill, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Terminated 2

Follow Critically Ill: new trials by email Literature Review of Critically Ill trials Research Report on Critically Ill

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Collaborative H1N1 Adjuvant Treatment Pilot Trial
Rosuvastatin, Placebo - Critically Ill, H1N1/Influenza Infection
Phase 2TerminatedCanadian Critical Care Trials Group82010-01-012013-02-21
The Efficacy of Glucagon Like Peptide (GLP) - 1(7-36) Amide for Glycemic Control in Critically Ill Patients
Glucagon-Like Peptide-1, Saline - Critically Ill, Hypoglycemia
Phase 2TerminatedJohns Hopkins University192008-12-012017-07-02

Narrower conditions

Critical Illness (2)  ·  Hypoglycemia (1)  ·  Respiratory Aspiration (1)

Broader conditions

Disease Attributes (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Glucose Metabolism Disorders (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Respiration Disorders (1)  ·  Respiratory Tract Diseases (1)

Interventions

Glucagon-Like Peptide 1 (1)  ·  Rosuvastatin Calcium (1)  ·  Sodium Chloride (1)

Sponsors

Canadian Critical Care Trials Group (1)  ·  Johns Hopkins University (1)

Countries

Canada (1)  ·  United States (1)

Top investigators

Dariush Elahi, PhD (1)  ·  John C Marshall, MD, FRCPS (1)  ·  Karen EA Burns, MD,FRCPC,MSc (1)